HopeStage
Back to all studies
CompletedNCT00086411

Counseling and medication options for lighter smokers

About this titleRead the official source — NCT00086411
Medication studyAges 18–75United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
PhiladelphiaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2003
Recruitment status
Completed
Enrollment listed in the registry
260
Sponsor
University of Pennsylvania
Sponsor type
University
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00086411
Official title
Show the full official title

Comparing Smoking Treatment Programs for Lighter Smokers

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pennsylvania, a university.

Did this study involve medication?

Yes. The study involved medication, including nicotine transdermal system, bupropion, placebo patch and placebo bupropion.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies